Biogen Inc (NASDAQ:BIIB) under-valued by 13%
| Website | https://www.biogen.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2019 |
| Market Cap | $44,329,222,000 |
| Beta | 0.57477 |
| Average Volume | $1,142,596 |
| Last Dividend | 0% |
| Price on Jul 22, 2020 | $280.63 |
| Autochartist™ Valuation | $316.45 |
| Conclusion |
13% under-valued |
| Download Report |
